Wogonin suppresses TARC expression induced by mite antigen via heme oxygenase 1 in human keratinocytes. Suppressive effect of wogonin on mite antigen-induced TARC expression

Journal of Dermatological Science

Volumn 46, Issue 1, 2007, Pages 31-40

  Lee, Bok Soo ^a   Shim, Sang Moo ^a   Heo, JungHee ^a   Pae, Hyun Ock ^a   Seo, Byeong Yun ^b   Han, Sang Youp ^b   Sohn, Dong Hwan ^b   Jang, Seon Il ^c   Chung, Hun Taeg ^a  

^a Wonkwang University School of Medicine   (South Korea)

^b Wonkwang University   (South Korea)

^c Seojeong College University   (South Korea)

Author keywords

Atopic dermatitis (AD); Carbon monoxide (CO); Heme oxygenase 1 (HO1); Mitogen activated protein kinases (MAPKs); Nuclear factor kappa B (NF kB); Thymus and activation regulated chemokine (TARC CCL17); Wogonin

Indexed keywords

HEME OXYGENASE 1; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MITOGEN ACTIVATED PROTEIN KINASE; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE; WOGONIN;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KERATINOCYTE; MITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCUTELLARIA BAICALENSIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CELL LINE, TRANSFORMED; CHEMOKINES, CC; DERMATITIS, ATOPIC; DERMATOPHAGOIDES FARINAE; DRUGS, CHINESE HERBAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVANONES; GENE EXPRESSION; HEME OXYGENASE-1; HUMANS; KERATINOCYTES; PHOSPHORYLATION; SCUTELLARIA BAICALENSIS;

EID: 33847638040     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2007.01.001     Document Type: Article

References (31)

1. Rudikoff D., and Lebwohl M. Atopic dermatitis. Lancet 351 9117 (1998) 1715-1721
2. Furukawa H., Nakamura K., Zheng X., Tojo M., Oyama N., Akiba H., et al. Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis. J Dermatol Sci 35 1 (2004) 35-42
3. Breuer K., Werfel T., and Kapp A. Allergic manifestations of skin diseases-atopic dermatitis. Chem Immunol Allergy 91 (2006) 76-86
4. Grewe M., Bruijnzeel-Koomen C.A., Schopf E., Thepen T., Langeveld-Wildschut A.G., Ruzicka T., et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19 8 (1998) 359-361
5. Vestergaard C., Bang K., Gesser B., Yoneyama H., Matsushima K., and Larsen C.G. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA + CCR4 + lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 115 4 (2000) 640-646
6. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 18 (2000) 217-242
7. Leung D.Y. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 105 5 (2000) 860-876
8. Kakinuma T., Nakamura K., Wakugawa M., Mitsui H., Tada Y., Saeki H., et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107 3 (2001) 535-541
9. Morita E., Hiragun T., Mihara S., Kaneko S., Matsuo H., Zhang Y., et al. Determination of thymus and activation-regulated chemokine (TARC)-contents in scales of atopic dermatitis. J Dermatol Sci 34 3 (2004) 237-240
10. Lim B.O. Efficacy of wogonin in the production of immunoglobulins and cytokines by mesenteric lymph node lymphocytes in mouse colitis induced with dextran sulfate sodium. Biosci Biotechnol Biochem 68 12 (2004) 2505-2511
11. Brandi M.L. Flavonoids: biochemical effects and therapeutic applications. Bone Miner 19 Suppl. 1 (1992) S3-S14
12. Lim B.O., Choue R.W., Lee H.Y., Seong N.S., and Kim J.D. Effect of the flavonoid components obtained from Scutellaria radix on the histamine, immunoglobulin E and lipid peroxidation of spleen lymphocytes of Sprague-Dawley rats. Biosci Biotechnol Biochem 67 5 (2003) 1126-1129
13. Zuckerbraun B.S., Billiar T.R., Otterbein S.L., Kim P.K., Liu F., Choi A.M., et al. Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. J Exp Med 198 11 (2003) 1707-1716
14. Wu L., and Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 57 4 (2005) 585-630
15. Otterbein L.E., Soares M.P., Yamashita K., and Bach F.H. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24 8 (2003) 449-455
16. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao Lu H., Wysk M., et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6 4 (2000) 422-428
17. Lee B.S., Heo J., Kim Y.M., Shim S.M., Pae H.O., and Chung H.T. Carbon monoxide mediates heme oxygenase 1 induction via Nrf2 activation in hepatoma cells. Biochem Biophys Res Commun 343 3 (2006) 965-972
18. Kietzmann T., Samoylenko A., and Immenschuh S. Transcriptional regulation of heme oxygenase-1 gene expression by MAP kinases of the JNK and p38 pathways in primary cultures of rat hepatocytes. J Biol Chem 278 20 (2003) 17927-17936
19. Pae H.O., Oh G.S., Choi B.M., Chae S.C., Kim Y.M., Chung K.R., et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 172 8 (2004) 4744-4751
20. Choi B.M., Pae H.O., Kim Y.M., and Chung H.T. Nitric oxide-mediated cytoprotection of hepatocytes from glucose deprivation-induced cytotoxicity: involvement of heme oxygenase-1. Hepatology 37 4 (2003) 810-823
21. Nakayama T., Hieshima K., Nagakubo D., Sato E., Nakayama M., Kawa K., et al. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J Virol 78 4 (2004) 1665-1674
22. Vestergaard C., Deleuran M., Gesser B., and Larsen C.G. Thymus- and activation-regulated chemokine (TARC/CCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice. Exp Dermatol 13 4 (2004) 265-271
23. Vestergaard C., Yoneyama H., Murai M., Nakamura K., Tamaki K., Terashima Y., et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 104 8 (1999) 1097-1105
24. Xiao T., Kagami S., Saeki H., Sugaya M., Kakinuma T., Fujita H., et al. Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells. J Dermatol Sci 31 2 (2003) 111-117
25. Tsuda T., Tohyama M., Yamasaki K., Shirakata Y., Yahata Y., Tokumaru S., et al. Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro. J Dermatol Sci 31 (2003) 37-42
26. Ryter S.W., Otterbein L.E., Morse D., and Choi A.M. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 234-235 1-2 (2002) 249-263
27. Pae H.O., Choi B.M., Oh G.S., Lee M.S., Ryu D.G., Rhew H.Y., et al. Roles of heme oxygenase-1 in the antiproliferative and antiapoptotic effects of nitric oxide on Jurkat T cells. Mol Pharmacol 66 1 (2004) 122-128
28. Brouard S., Berberat P.O., Tobiasch E., Seldon M.P., Bach F.H., and Soares M.P. Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J Biol Chem 277 20 (2002) 17950-17961
29. Salinas M., Wang J., Rosa de Sagarra M., Martin D., Rojo A.I., Martin-Perez J., et al. Protein kinase Akt/PKB phosphorylates heme oxygenase-1 in vitro and in vivo. FEBS Lett 578 1-2 (2004) 90-94
30. Durante W., Christodoulides N., Cheng K., Peyton K.J., Sunahara R.K., and Schafer A.I. cAMP induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle. Am J Physiol 273 1 (Pt. 2) (1997) H317-H323
31. Morse D., Pischke S.E., Zhou Z., Davis R.J., Flavell R.A., Loop T., et al. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 278 39 (2003) 36993-36998